TrialBMC cancer2012

Clinical outcomes of HER2-positive metastatic breast cancer patients with brain metastasis treated with lapatinib and capecitabine: an open-label expanded access study in Korea.

Jungsil Ro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.